The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...
Panelists discuss how Brandi first noticed symptoms leading to her paroxysmal nocturnal hemoglobinuria (PNH) diagnosis, highlighting the challenges of the initial diagnostic process, and explore the ...
Hispanic/Latinx communities are the fastest-growing population in the US. In 2023,the US Census Bureau reported that the ...
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback